Skip to content

PML causing immune reconstitution problems when ARVs begin

Treating PML: hopes for future focus on mastering immune response

Patients who don't visit their HIV clinic regularly have increased risk of death

WHO spells out how d4T dose reduction should be implemented

Clinton Foundation announces new price cuts for tenofovir and second-line drugs

Brazil issues compulsory license on efavirenz

Levels of albumin in urine higher in people with HIV, association with risk of heart and kidney disease

Tenofovir and Truvada — what to do with them if you can get your hands on them?

Treatment failure in severe pneumonia highlights need to revise WHO guidelines for acute respiratory infections in South African children